Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 10 unusual trades.
Delving into the details, we found 30% of traders were bullish, while 70% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $88,487, and 7 were calls, valued at $365,580.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $145.0 for Novo Nordisk, spanning the last three months.
Insights into Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Novo Nordisk options trades today is 1083.25 with a total volume of 720.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Novo Nordisk's big money trades within a strike price range of $100.0 to $145.0 over the last 30 days.
Novo Nordisk Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|
| NVO | CALL | SWEEP | BEARISH | 09/20/24 | $17.25 | $17.05 | $17.05 | $120.00 | $178.5K | 1.1K | 132 |
| NVO | CALL | TRADE | BULLISH | 01/17/25 | $37.4 | $37.2 | $37.4 | $100.00 | $37.4K | 1.7K | 15 |
| NVO | CALL | TRADE | BEARISH | 09/20/24 | $18.15 | $17.9 | $17.9 | $120.00 | $35.8K | 1.1K | 26 |
| NVO | PUT | SWEEP | BEARISH | 06/21/24 | $9.0 | $8.9 | $9.0 | $140.00 | $31.4K | 496 | 37 |
| NVO | PUT | SWEEP | BEARISH | 06/21/24 | $9.05 | $8.9 | $8.95 | $140.00 | $31.4K | 496 | 37 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Where Is Novo Nordisk Standing Right Now?
- Trading volume stands at 1,844,849, with NVO's price up by 0.06%, positioned at $132.49.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 86 days.
What The Experts Say On Novo Nordisk
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.0.
- An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $160.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from Benzinga Pro.
金融巨頭對諾和諾德採取了明顯的看跌舉動。我們對諾和諾德（紐約證券交易所代碼：NVO）期權歷史的分析顯示了10筆不尋常的交易。
深入研究細節，我們發現30％的交易者看漲，而70％的交易者表現出看跌趨勢。在我們發現的所有交易中，有3筆是看跌期權，價值爲88,487美元，7筆是看漲期權，價值365,580美元。
預期的價格走勢
在評估了交易量和未平倉合約之後，很明顯，主要市場走勢者正在關注過去三個月諾和諾德在100.0美元至145.0美元之間的價格區間。
對交易量和未平倉合約的見解
就流動性和利息而言，今天諾和諾德期權交易的平均未平倉合約爲1083.25，總交易量爲720.00。
在下圖中，我們可以跟蹤過去30天內諾和諾德在100.0美元至145.0美元行使價區間內的大額資金交易的看漲和看跌期權交易量和未平倉合約的變化。
Novo Nordisk 看漲和看跌交易量：30 天概述
檢測到的重要期權交易：
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|
NVO | CALL | SWEEP | BEARISH | 09/20/24 | $17.25 | $17.05 | $17.05 | $120.00 | $178.5K | 1.1K | 132 |
NVO | CALL | TRADE | BULLISH | 01/17/25 | $37.4 | $37.2 | $37.4 | $100.00 | $37.4K | 1.7K | 15 |
NVO | CALL | TRADE | BEARISH | 09/20/24 | $18.15 | $17.9 | $17.9 | $120.00 | $35.8K | 1.1K | 26 |
NVO | PUT | SWEEP | BEARISH | 06/21/24 | $9.0 | $8.9 | $9.0 | $140.00 | $31.4K | 496 | 37 |
NVO | PUT | SWEEP | BEARISH | 06/21/24 | $9.05 | $8.9 | $8.95 | $140.00 | $31.4K | 496 | 37 |
關於 Novo Nordisk
諾和諾德擁有全球品牌糖尿病治療市場約三分之一的份額，是全球領先的糖尿病護理產品提供商。該公司總部位於丹麥，生產和銷售各種人用和現代胰島素、注射型糖尿病治療藥物（如 GLP-1 療法）、口服抗糖尿病藥物和肥胖療法。Novo還有一個生物製藥板塊（約佔收入的10％），專門研究血友病和其他疾病的蛋白質療法。
諾和諾德現在處於什麼位置？
專家對諾和諾德的看法
在過去的30天中，共有1位專業分析師對該股發表了看法，將平均目標股價定爲160.0美元。
期權交易帶來更高的風險和潛在的回報。精明的交易者通過不斷自我教育、調整策略、監控多個指標以及密切關注市場走勢來管理這些風險。通過Benzinga Pro的實時提醒，隨時了解Novo Nordisk的最新期權交易。
